ProPhase Labs, Inc.
PRPHNASDAQHealthcare● Active
$0.10
$-0.01(-9.09%)
Market Cap$473701
P/E Ratio—
52W High$6.7
52W Low$0.07
ProPhase Labs, Inc.（PRPH）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PRPH · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($14.74M) | ($49.52M) | ($16.78M) | $18.46M | $6.27M |
| Depreciation & Amort. | $5.06M | $6.64M | $6.70M | $5.06M | $3.56M |
| Stock-Based Comp. | $1.89M | $3.64M | $3.54M | $3.99M | $3.18M |
| Change in Working Capital | ($0.18M) | $14.89M | ($5.70M) | ($4.34M) | ($26.88M) |
| Net Cash from Operations | ($8.34M) | ($17.54M) | ($11.35M) | $28.55M | ($13.62M) |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | ($0.91M) | ($3.15M) | ($3.92M) | ($4.23M) |
| Purchases of Investments | $0.00M | $0.00M | ($3.82M) | ($6.78M) | ($21.53M) |
| Sales of Investments | $0.00M | $3.37M | $7.99M | $8.17M | $15.86M |
| Net Cash from Investing | $0.92M | $2.42M | ($1.37M) | ($2.08M) | ($19.67M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | ($5.97M) | ($9.63M) | ($0.92M) |
| Dividends Paid | $0.00M | $0.00M | $0.00M | ($9.35M) | ($4.55M) |
| Debt Issued / Repaid | $3.31M | $5.61M | $10.52M | ($7.04M) | ($0.04M) |
| Net Cash from Financing | $6.84M | $14.19M | $5.76M | ($26.02M) | $35.13M |
| Free Cash Flow | |||||
| Free Cash Flow | ($8.94M) | ($18.44M) | ($14.50M) | $24.63M | ($17.85M) |
| FCF Margin %(computed) | -205.78% | -272.44% | -32.68% | 20.08% | -22.58% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解ProPhase Labs, Inc.
关于ProPhase Labs, Inc.（PRPH）现金流量表
ProPhase Labs, Inc. 2025财年经营活动现金流($0.01B)，自由现金流($0.01B)（FCF利润率-205.78%），资本支出$0.00B。
常见问题
PRPH · 4 问ProPhase Labs, Inc. 2025财年自由现金流($0.01B)，同比up51.5%。
PRPH free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10